TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 214,286 common shares of the Company at a deemed price of $0.07 per share, for a total value of $15,000, to an arm’s length service provider in settlement of services provided, as previously described in the Company’s press release dated April 8, 2015. The shares issued are subject to a four month hold period which will expire on August 10, 2015.
CardioComm Solutions Completes Share Issuance Under HeartCheck™ PEN US Retail Pharmacy Consulting Agreement
by cardiocomm | Apr 8, 2015 | Press Release | 0 comments